mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
3e-05 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0001 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |